Clinical trials and protocols
Intestinal permeability and low-grade chronic inflammation in schizophrenia: A multicentre study on biomarkers. Rationale, objectives, protocol and preliminary results
Gerard Anmellaa,b,c,1, Silvia Amorettia,b,c,d,1, Gemma Safontb,e, Ana Meseguera,b,c, Eduard Vietaa,b, Maria Teresa Pons-Cabreraa,b,c, Miqueu Alfonsof, Carla Hernándezf, Monica Sanchez-Autetf, Ferran Pérez-Baldelloue, Leticia González-Blancog,h, Maria Paz García-Portillag,h, Miquel Bernardob,c,
, Belén Arranzb,f
Corresponding author
a Bipolar and Depressive Disorders Unit, Hospital Clínic de Barcelona, Institute of Neuroscience, August Pi i Sunyer Biomedical Research Institute (IDIBAPS), University of Barcelona, Barcelona, Catalonia, Spain
b Biomedical Research Networking Center for Mental Health Network (CIBERSAM), Barcelona, Spain
c Barcelona Clinic Schizophrenia Unit, Hospital Clínic de Barcelona, Institute of Neuroscience, University of Barcelona, IDIBAPS, Spain
d Group of Psychiatry, Mental Health and Addictions, Vall d’Hebron Research Institute (VHIR), Psychiatric Genetics Unit, Vall d’Hebron Research Institute (VHIR), Barcelona, Catalonia, Spain
e Department of Psychiatry, Hospital Universitari Mutua de Terrassa, Universitat de Barcelona, Barcelona, Spain
f Department of Psychiatry, Hospital Parc Sanitari Sant Joan de Déu, Barcelona, Spain
g Department of Psychiatry, University of Oviedo, Servicio de Salud Mental del Principado de Asturias, Oviedo, Spain
h Instituto de Investigación Sanitaria del Principado de Asturias (ISPA), INEUROPA, Biomedical Research Networking Center for Mental Health Network (CIBERSAM), Oviedo, Spain
